ACM
ABMD
American Capital Management’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-270,696
| Closed | -$66.5M | – | 64 |
|
|
2022
Q3 | $66.5M | Sell |
270,696
-679
| -0.3% | -$167K | 2.62% | 13 |
|
|
2022
Q2 | $67.2M | Buy |
271,375
+72
| +0% | +$17.8K | 2.52% | 16 |
|
|
2022
Q1 | $89.9M | Buy |
271,303
+8,383
| +3% | +$2.78M | 2.65% | 15 |
|
|
2021
Q4 | $94.4M | Buy |
262,920
+12,272
| +5% | +$4.41M | 2.42% | 13 |
|
|
2021
Q3 | $81.6M | Buy |
250,648
+17,996
| +8% | +$5.86M | 2.19% | 16 |
|
|
2021
Q2 | $72.6M | Buy |
232,652
+11,413
| +5% | +$3.56M | 2.03% | 17 |
|
|
2021
Q1 | $70.5M | Buy |
221,239
+1,566
| +0.7% | +$499K | 2.13% | 16 |
|
|
2020
Q4 | $71.2M | Buy |
219,673
+441
| +0.2% | +$143K | 2.13% | 20 |
|
|
2020
Q3 | $60.7M | Sell |
219,232
-1,855
| -0.8% | -$514K | 2.23% | 19 |
|
|
2020
Q2 | $53.4M | Buy |
221,087
+6,836
| +3% | +$1.65M | 1.96% | 20 |
|
|
2020
Q1 | $31.1M | Buy |
214,251
+65,457
| +44% | +$9.5M | 1.51% | 26 |
|
|
2019
Q4 | $25.4M | Buy |
148,794
+25,124
| +20% | +$4.29M | 1.06% | 30 |
|
|
2019
Q3 | $22M | Buy |
123,670
+43,357
| +54% | +$7.71M | 0.97% | 33 |
|
|
2019
Q2 | $20.9M | Buy |
+80,313
| New | +$20.9M | 0.9% | 35 |
|